Cubist Pharmaceuticals, Inc. - Product Pipeline Review - 2012


Naperville, IL -- (SBWIRE) -- 06/06/2012 -- Cubist Pharmaceuticals Product Pipeline Review 2012 provides data on the Cubist Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Cubist Pharmaceuticals, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Cubist Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.


- Cubist Pharmaceuticals, Inc. - Brief Cubist Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Cubist Pharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Cubist Pharmaceuticals, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Cubist Pharmaceutical’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Cubist Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Cubist Pharmaceuticals, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Cubist Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Cubist Pharmaceuticals, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Cubist Pharmaceuticals, Inc. and identify potential opportunities in those areas.


Current R&D Portfolio of Cubist Pharmaceuticals, Inc.; Cubist Pharmaceuticals, Inc. - Key Therapeutics; Cubist Pharmaceuticals, Inc. - Pipeline Overview and Promising Molecules; Cubist Pharmaceuticals, Inc. - News; Cubist Pharmaceuticals, Inc. - Latest Updates; Cubist Pharmaceuticals, Inc. - Pipeline; Cubist Pharmaceuticals, Inc. - Discontinued/Dormant Projects

To view the detailed table of contents for this report please visit: